Theriva Biologics Raises $4 Million: Warrant Deal Fuels Cancer-Fighting Virus Research
Most cancer treatments attack tumours directly with chemicals or radiation—blunt instruments causing collateral damage throughout the body. Theriva Biologics takes a fundamentally different approach: engineering viruses that selectively invade cancer cells, replicate inside them, and trigger immune responses while breaking down the protective barriers tumours build around themselves. This innovative strategy targets some of medicine’s […]
Theriva Biologics Raises $4 Million: Warrant Deal Fuels Cancer-Fighting Virus Research Read More »










